Cargando…
Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells
[Image: see text] Molecular targeting of tumor-overexpressed oncoproteins can improve the selectivity and tolerability of anticancer therapies. The immunoinhibitory membrane protein programmed death ligand 1 (PD-L1) is highly expressed on certain tumor types, which masks malignant cells from T cell...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326819/ https://www.ncbi.nlm.nih.gov/pubmed/35911461 http://dx.doi.org/10.1021/jacsau.2c00328 |